Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 58.7038.9439.7526.5021.60

What is the latest Cash Earnings per Share (CEPS) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 58.70 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202558.70
Mar202438.94
Mar202339.75
Mar202226.50
Mar202121.60

How is Cash Earnings per Share (CEPS) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 58.7
50.74
Mar2024 38.94
-2.04
Mar2023 39.75
50.00
Mar2022 26.5
22.69
Mar2021 21.6 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹54,924.6 Cr -1.2% -2.3% 27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

-2.3%

27.2%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses